<DOC>
	<DOCNO>NCT02182609</DOCNO>
	<brief_summary>The objective study : - To determine safety tolerability single dose 99mTc-rhAnnexin V-128 administer intravenous bolus 10-20 second . - To determine biodistribution , pharmacokinetics radiation dosimetry 99mTc-rhAnnexin V-128 normal healthy adult volunteer .</brief_summary>
	<brief_title>99mTc-rhAnnexin V-128 : First In Man Study Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>1 . Age 18 65 year 2 . No significant medical history 3 . Normal physical examination 4 . No clinically significant abnormality baseline laboratory value 5 . No clinically significant abnormality 12 lead electrocardiogram 6 . Female subject must postmenopausal , surgically sterilize negative urine beta human chorionic gonadotropin pregnancy test initial screen preinjection dose day 7 . Written inform consent sign 1 . Pregnancy lactation 2 . Know hypersensitivity investigational drug component 3 . Current enrolment another investigational study 4 . Unwillingness provide continue inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>